AI Medical Service Inc. (AMS) is a pioneering Japanese med-tech company dedicated to leveraging artificial intelligence to enhance the accuracy and efficiency of endoscopic diagnostics. Founded with the mission to 'Save Lives All Over the World,' AMS develops AI software that assists physicians in detecting gastrointestinal cancers, including gastric, colorectal, and esophageal cancer, at earlier stages. Their technology aims to address the global challenge of cancer by supporting medical professionals, reducing diagnostic oversights, and improving patient outcomes. AMS collaborates closely with leading medical institutions to develop and validate its AI solutions, striving to make advanced cancer screening more accessible globally.
Serves as the central hub for research and development, corporate strategy, business development, and global operations management for AI-powered endoscopic diagnostic solutions.
Located in Hareza Tower, a modern office complex in the vibrant Ikebukuro district, known for its advanced facilities, sustainability features, and direct connection to major transport links.
A highly collaborative and innovative environment focused on cutting-edge medical technology development, driven by a strong mission to impact global health. Emphasizes research, precision, ethical AI development, and teamwork among diverse specialists.
The Tokyo HQ is pivotal for AMS's innovation, leveraging Japan's advanced medical imaging expertise and fostering collaborations with leading Japanese medical institutions for AI development, clinical trials, and validation.
AI Medical Service Inc. is actively expanding its global footprint from its headquarters in Tokyo, Japan. The company supports clinical research and product deployment internationally, with dedicated subsidiaries in the United States (AI Medical Service USA Inc. in Santa Clara, CA) to target the North American market, and in Singapore (AI Medical Service Asia Pte. Ltd.) to serve as a hub for the broader Asia-Pacific region. Their AI-powered endoscopic diagnostic solutions are being developed and trialed in collaboration with medical institutions worldwide, aiming to address global needs in early cancer detection. Functions supported globally include international business development, regulatory affairs management for different jurisdictions, localized clinical trial coordination, and market-specific product adaptation and support.
Hareza Tower 19F, 1-18-1 Higashi-Ikebukuro
Toshima-ku, Tokyo
Tokyo
Japan
Address: Santa Clara, California, USA (Specific street address not publicly detailed)
To spearhead expansion into the significant U.S. healthcare market, navigate complex regulatory pathways, and build partnerships for commercialization, clinical research, and product adoption.
Address: Singapore (Specific street address not publicly detailed, likely in a central business or tech hub)
To drive growth and adoption of AMS's AI solutions in the diverse and rapidly growing healthcare markets across the Asia-Pacific region, leveraging Singapore's position as a biomedical and technological hub.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AI Medical Service Inc.' leadership includes:
AI Medical Service Inc. has been backed by several prominent investors over the years, including:
AI Medical Service Inc. has made strategic additions to its leadership to support global expansion and regulatory efforts, notably appointing Kyoko Ko as Head of Regulatory Strategy & Affairs. No major C-suite departures have been publicly announced in the last 12 months, indicating stability in the core executive team.
Discover the tools AI Medical Service Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AI Medical Service Inc. likely utilizes standard professional email formats. Common patterns for technology companies include [first_initial][last_name]@[companydomain.com] or [first_name].[last_name]@[companydomain.com]. The exact format can vary by department or individual preference.
[first_initial][last_name]@aimedicalservice.com (e.g., ttada@aimedicalservice.com) and [first_name].[last_name]@aimedicalservice.com (e.g., tomohiro.tada@aimedicalservice.com)
Format
ttada@aimedicalservice.com
Example
75%
Success rate
AI Medical Service Inc. Official Website / PR Newswire • May 14, 2024
AI Medical Service Inc. announced it secured approximately $51 million (8 billion JPY) in a Series C funding round. The round was led by existing investors Globis Capital Partners and World Innovation Lab (WiL), with new participation from Newton Investment Management. Funds will fuel global business expansion, particularly in the U.S. and Asia, and enhance R&D for its AI-powered endoscopic diagnostic support systems....more
AI Medical Service Inc. Official Website • October 26, 2023
AI Medical Service Inc. announced the establishment of its Singaporean subsidiary, AI Medical Service Asia Pte. Ltd. This strategic move aims to create a hub for expanding its AI-based endoscopic diagnostic support system business into the broader Asian market, leveraging Singapore's strategic location and robust healthcare ecosystem....more
AI Medical Service Inc. Official Website • June 14, 2023
AI Medical Service Inc. appointed Ms. Kyoko Ko, who previously served at Japan's Ministry of Health, Labour and Welfare (MHLW), as its new Head of Regulatory Strategy & Affairs. This appointment is expected to significantly strengthen AMS's capabilities in navigating global regulatory requirements for its medical AI devices....more
AI Medical Service Inc. Official Website / PR Newswire • May 24, 2023
AI Medical Service Inc. (AMS) announced the establishment of its U.S. subsidiary, AI Medical Service USA Inc., located in Santa Clara, California. This initiative is a key step in AMS's strategy to accelerate global business development and introduce its AI-powered endoscopic diagnostic support system to the U.S. healthcare market....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AI Medical Service Inc., are just a search away.